Martine Escoffre
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Remote Monitoring of CAR T-Cell Treated Patients by a Specialized Nurse to Detect and Manage Late Complications: Report of the CARAMA Program.
Journal: Hematological oncology
Published: November 22, 2024
Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel.
Journal: HemaSphere
Published: April 01, 2024
Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Journal: Leukemia & lymphoma
Published: February 25, 2020
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
Journal: Leukemia
Published: July 12, 2019
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
Journal: Clinical chemistry and laboratory medicine
Published: December 24, 2018
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
Journal: Cancer
Published: April 10, 2017
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.
Journal: The New England journal of medicine
Published: April 06, 2017
Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 17, 2016
NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: October 13, 2015
Last Updated: 09/26/2026